Merck Manual

Please confirm that you are a health care professional

honeypot link

Sinusoidal Obstruction Syndrome

(Veno-Occlusive Disease)

By

Whitney Jackson

, MD, University of Colorado School of Medicine

Reviewed/Revised Jan 2022 | Modified Sep 2022
View Patient Education

Hepatic sinusoidal obstruction syndrome is caused by endothelial injury, leading to nonthrombotic occlusion of the terminal hepatic venules and hepatic sinusoids, rather than of the hepatic veins or inferior vena cava (as in Budd-Chiari syndrome Budd-Chiari Syndrome Budd-Chiari syndrome is obstruction of hepatic venous outflow that originates anywhere from the small hepatic veins inside the liver to the inferior vena cava and right atrium. Manifestations... read more ).

Etiology of Sinusoidal Obstruction Syndrome

Common causes include

Pearls & Pitfalls

  • Ask patients who have cryptogenic liver abnormalities about use of herbal and natural products (including bush and herb teas) and anabolic steroids (which can cause peliosis hepatis).

Symptoms and Signs of Sinusoidal Obstruction Syndrome

Diagnosis of Sinusoidal Obstruction Syndrome

  • Clinical evaluation and liver tests

  • Ultrasonography

  • Sometimes invasive tests (eg, liver biopsy, measurement of portal-hepatic venous pressure gradient)

The diagnosis is suspected in patients with unexplained clinical or laboratory evidence of liver disease, particularly in those with known risk factors, such as bone marrow or hematopoietic cell transplantation.

Laboratory results are nonspecific: elevated aminotransferase and conjugated bilirubin levels. Prothrombin time/international normalized ratio (PT/INR) becomes abnormal when disease is severe. Ultrasonography shows retrograde flow in the portal vein.

Treatment of Sinusoidal Obstruction Syndrome

  • Supportive care

  • Treatment of cause

  • For progressive disease, transjugular intrahepatic portosystemic shunting or transplantation

Management includes withdrawing the causative agent (such as herbal teas) and providing supportive therapy. Defibrotide, a sodium salt of single-stranded oligodeoxyribonucleotide, has been demonstrated to protect endothelial cells from further activation, and may be considered in patients with sinusoidal obstruction syndrome that complicates hematopoietic stem cell transplantation (1 Treatment reference Hepatic sinusoidal obstruction syndrome is caused by endothelial injury, leading to nonthrombotic occlusion of the terminal hepatic venules and hepatic sinusoids, rather than of the hepatic... read more ).

Treatment reference

  • 1. Richardson PG, Riches ML, Kernan NA, et al: Phase 3 trial of defibrotide for the treatment of severe veno-occlusive disease and multi-organ failure. Blood 27(13):1656-1665, 2016. doi: 10.1182/blood-2015-10-676924

Drugs Mentioned In This Article

Drug Name Select Trade
Azasan, Imuran
Actigall, Reltone, Urso 250, Urso Forte
Defitelio
View Patient Education
NOTE: This is the Professional Version. CONSUMERS: View Consumer Version
quiz link

Test your knowledge

Take a Quiz! 
iOS ANDROID
iOS ANDROID
iOS ANDROID
TOP